[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Mi et al., 1999 - Google Patents

Chitosan microspheres: modification of polymeric chem‐physical properties of spray‐dried microspheres to control the release of antibiotic drug

Mi et al., 1999

Document ID
10740137932977784837
Author
Mi F
Wong T
Shyu S
Chang S
Publication year
Publication venue
Journal of Applied Polymer Science

External Links

Snippet

Antibiotic drug releasing from chitosan and acylchitosan microspheres was studied. The acylchitosan microspheres were prepared by modifying the microencapsulation process from spray‐drying to spray in‐liquid coagulating process for the improvement of chem …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Similar Documents

Publication Publication Date Title
Mi et al. Chitosan microspheres: modification of polymeric chem‐physical properties of spray‐dried microspheres to control the release of antibiotic drug
Chen et al. Polycaprolactone microparticles and their biodegradation
Denkbaş et al. Chitosan microspheres and sponges: preparation and characterization
Shi et al. Preparation of chitosan/ethylcellulose complex microcapsule and its application in controlled release of Vitamin D2
Suzuki et al. Microencapsulation and dissolution properties of a neuroleptic in a biodegradable polymer, poly (d, l-lactide)
Mi et al. The study of gelation kinetics and chain-relaxation properties of glutaraldehyde-cross-linked chitosan gel and their effects on microspheres preparation and drug release
Işiklan Controlled release of insecticide carbaryl from sodium alginate, sodium alginate/gelatin, and sodium alginate/sodium carboxymethyl cellulose blend beads crosslinked with glutaraldehyde
Wang et al. Properties of chitosan/poly (vinyl alcohol) films for drug‐controlled release
Shin et al. Dopamine‐loaded poly (d, l‐lactic‐co‐glycolic acid) microspheres: New strategy for encapsulating small hydrophilic drugs with high efficiency
Fu, F.-L. Mi, T.-B. Wong, S.-S. Shyu Characteristic and controlled release of anticancer drug loaded poly (D, L-lactide) microparticles prepared by spray drying technique
Voon et al. Porous cellulose beads fabricated from regenerated cellulose as potential drug delivery carriers
Wang et al. Polymer encapsulation of fine particles by a supercritical antisolvent process
Xie et al. Antibiotic drug release behavior of poly (vinyl alcohol)/sodium alginate hydrogels
Pang et al. Preparation and application performance of lignin-polyurea composite microcapsule with controlled release of avermectin
Jalil et al. Microencapsulation using poly (L-lactic acid) IV: Release properties of microcapsules containing phenobarbitone
Luo et al. Preparation and characterization of genipin-crosslinked chitosan microspheres for the sustained release of salidroside
Chen et al. Preparation, characterization and in vitro release properties of morphine-loaded PLLA-PEG-PLLA microparticles via solution enhanced dispersion by supercritical fluids
Wu et al. Optimization of the preparation of nalmefene-loaded sustained-release microspheres using central composite design
Erden et al. Factors influencing release of salbutamol sulphate from poly (lactide-co-glycolide) microspheres prepared by water-in-oil-in-water emulsion technique
Baimark et al. Preparation of porous silk fibroin microparticles by a water‐in‐oil emulsification‐diffusion method
Ma et al. PCL/poloxamer 188 blend microsphere for paclitaxel delivery: Influence of poloxamer 188 on morphology and drug release
Ren et al. Particle size and distribution of biodegradable poly‐D, L‐lactide‐co‐poly (ethylene glycol) block polymer nanoparticles prepared by nanoprecipitation
da Silva et al. Metformin hydrochloride sustained release biopolymeric system composed by PLLA‐CMC microparticles
Chang et al. Preparation and preliminary characterization of concentric multi‐walled chitosan microspheres
He et al. Cagelike polymer microspheres with hollow core/porous shell structures